Physician profile
Amanda A Thomas
NPI 1669634390
$623.21
in general payments reported to CMS, 2019-2025
12 companies · $23.70 in 2025
The $23.70 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $15.03 · 2024: $18.06 · 2025: $23.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $87.33 | 2021 | |
| Alk-Abello, INC | $84.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $84.66 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $80.47 | 2021 | |
| Csl Behring | $64.21 | 2021-2024 | Haegarda |
| Glaxosmithkline, LLC. | $64.03 | 2021 | |
| Genzyme Corporation | $39.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.58 | 2021 | |
| Pfizer INC. | $26.49 | 2021 | |
| Abbott Laboratories | $23.70 | 2025 | Cardiomems |
| Takeda Pharmaceuticals U.S.A., INC. | $17.90 | 2021 | |
| Aimmune Therapeutics, INC. | $14.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.